Table 3 Direct and indirect patient costs before and during treatment
All (n = 110) | Private (n = 50) | NTP (n = 60) | P-value¥ | ||||
|---|---|---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | ||
Pre- & treatment costs | |||||||
Direct medical costs | 599 (630) | 402 (147–839) | 974 (696) | 754 (508–1223) | 287 (334) | 164 (61–398) | < 0.001 |
Direct non-medical costs | 456 (493) | 355 (196–542) | 539 (670) | 398 (133–648) | 388 (255) | 345 (233–480) | 0.737 |
Indirect costs | 1347 (2938) | 585 (0–1548) | 1732 (4121) | 710 (0–1806) | 1025 (1270) | 578 (0–1527) | 0.954 |
Total pre- & treatment costs | 2402 (3257) | 1726 (879–2820) | 3246 (4481) | 2075 (1229–3481) | 1700 (1349) | 1313 (652–2174) | 0.005 |
Pre-treatment costs | |||||||
Direct medical costs | 221 (343) | 138 (55–212) | 268 (441) | 153 (85–213) | 181 (229) | 99 (43–202) | 0.028 |
Direct non-medical costs | 28 (55) | 9 (4–25) | 21 (31) | 6 (3–22) | 34 (68) | 9 (5–30) | 0.053 |
Total pre-treatment costs | 248 (371) | 151 (72–236) | 288 (455) | 166 (92–235) | 248 (371) | 114 (53–245) | 0.065 |
Treatment costs | |||||||
Direct medical costs | 379 (477) | 198 (15–621) | 707 (476) | 609 (350–970) | 106 (253) | 16 (1–98) | < 0.001 |
Direct non-medical costs | 429 (486) | 329 (153–530) | 519 (659) | 384 (131–637) | 354 (251) | 315 (188–429) | 0.560 |
Indirect costs | 1347 (2938) | 585 (0–1548) | 1732 (4121) | 710 (0–1806) | 1025 (1270) | 578 (0–1527) | 0.954 |
Total treatment costs | 2154 (3180) | 1541 (737–2477) | 2957 (4390) | 1864 (969–2967) | 1485 (1293) | 1111 (527–1995) | 0.004 |